Pamela Noldner

Duke University — United States

Medicine · Health Sciences

3h-index50citations24works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mesenchymal stem cell research(13), Tissue Engineering and Regenerative Medicine(6), Glioma Diagnosis and Treatment(4), Pluripotent Stem Cells Research(4), Hematopoietic Stem Cell Transplantation(3)

Publications24 total

The promise of TIL therapy for glioblastoma
Trends in cancer·2025
RXR agonist IRX4204 enhances BCMA CAR-T-cell efficacy by suppressing ferroptosis via CHAC1 downregulation
Blood·2025
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion
2025Open Access
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion
2025Open Access
CTIM-16. DEVELOPING PATIENT SPECIFIC TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH INCREASED TUMOR SPECIFICITY AS A THERAPY FOR GLIOBLASTOMA
Neuro-Oncology·2023Open Access
Mesenchymal Stem/Stromal Cells: DEVELOPING A POTENCY ASSAY FOR CORD TISSUE MESENCHYMAL STROMAL CELLS
Cytotherapy·2023
Process Development and Manufacturing: NEW APPROACHES FOR EXPANDING GLIOBLASTOMA INFILTRATING LYMPHOCYTES
Cytotherapy·2023
Abstract 3193: Developing non-exhausted tumor infiltrating lymphocytes (TILs) as a therapy for glioblastoma
Cancer Research·2023· 1 cited
Abstract 18 Developing a Potency Assay for Cord Tissue MSCs
Stem Cells Translational Medicine·2022Open Access
Abstract 24 Improving Cord Blood Unit Selection and Optimizing Manufacturing of a Unique Cord Blood-Derived Product (DUOC-01)
Stem Cells Translational Medicine·2022Open Access
Use of Ultra-Low Attachment Flasks Aids Manufacturing of the Macrophage-Like Cell Therapy Product DUOC-01 but Changes Product Phenotype
Stem Cells Translational Medicine·2019Open Access
Source Cell Preparation for the Manufacture of DUOC-01 Using a Closed System Cell-Processing Device
Stem Cells Translational Medicine·2019Open Access
Optimization of Human Umbilical Cord-Derived Mesenchymal Stem Cell Growth and Expansion Using a Closed-System Hollow Fiber Bioreactor
Stem Cells Translational Medicine·2019· 3 citedOpen Access
Meeting the demands of msc production for clinical studies
Cytotherapy·2019
Expanding and Streamlining Cord Tissue-Derived Mesenchymal Stem Cells Manufacture
Stem Cells Translational Medicine·2018Open Access
Manufacturing of allogeneic human cord tissue mesenchymal stromal cells: Initial results of a phase I clinical trial in children with autism spectrum disorder
Cytotherapy·2018· 1 cited
Targeting neuroinflammation with human umbilical cord tissue-derived mesenchymal stromal cells
Cytotherapy·2018
Characterization of msc derived from umbilical cord tissues
Cytotherapy·2017· 3 cited
Umbilical cord tissue derived mesenchymal stromal cells inhibit lysophosphatidylcholine mediated activation of microglia in organotypic cerebellar cultures
Cytotherapy·2017
Development and validation of a rapid, aldehyde dehydrogenase bright–based cord blood potency assay
Blood·2016· 40 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Joanne Kurtzberg(10), Beth H. Shaz(8), Kevin Shoulars(6), Lynn Cheatham(6), Roberta Parrott(6), Kelly Hotchkiss(6), Mustafa Khasraw(6), Kristin Page(5), Tracy Gentry(5), Andrew E. Balber(5), N. Meadows(5), Robert W. Storms(4), Barbara Ressler(4), J. Kurtzberg(4), Anthony J. Filiano(4), Kirit Singh(4), Jesse D. Troy(3), M. Lillich(3), A. Rudisill(3), Peter E. Fecci(3)